Clinical trial
Pilot Study To Identify Effective Methods Of Training Pump Naïve Subjects To Use The Paradigm® 722 System And To Describe Clinical Effectiveness Compared To Subjects Continuing With Multiple Dose Injections (MDI) of Insulin
NCT00530023 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study To Identify Effective Methods Of Training Pump Naïve Subjects To Use The Paradigm® 722 System And To Describe Clinical Effectiveness Compared To Subjects Continuing With Multiple Dose Injections (MDI) of Insulin
- Lead sponsor
- Medtronic MiniMed, Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- September 30, 2006
- Enrollment
- 29 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes